Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1995 1
2008 1
2015 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Premature ovarian failure 2A"
Page 1
Erxian decoction alleviates cisplatin-induced premature ovarian failure in rats by reducing oxidation levels in ovarian granulosa cells.
Liu J, Yang Y, He Y, Feng C, Ou H, Yang J, Chen Y, You F, Shao B, Bao J, Guan X, Chen F, Zhao P. Liu J, et al. J Ethnopharmacol. 2023 Mar 25;304:116046. doi: 10.1016/j.jep.2022.116046. Epub 2022 Dec 22. J Ethnopharmacol. 2023. PMID: 36567042
ETHNOPHARMACOLOGICAL RELEVANT: Erxian Decoction (EXD) has been used empirically for more than 70 years to treat premature ovarian failure (POF), but more research is needed to understand how it works. ...By using HE stains, pathological alterations in the ova …
ETHNOPHARMACOLOGICAL RELEVANT: Erxian Decoction (EXD) has been used empirically for more than 70 years to treat premature ovarian …
Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases.
Tarín JJ, García-Pérez MA, Hamatani T, Cano A. Tarín JJ, et al. Reprod Biol Endocrinol. 2015 Apr 15;13:31. doi: 10.1186/s12958-015-0029-9. Reprod Biol Endocrinol. 2015. PMID: 25880215 Free PMC article. Review.
Data show that different infertility etiologies not only share particular genes and/or molecular pathways with other pathologies but they have distinct clinical relationships with other diseases appearing after infertility is manifested. In particular, (1) testicular and h …
Data show that different infertility etiologies not only share particular genes and/or molecular pathways with other pathologies but they ha …
Fragile X testing in obstetrics and gynaecology in Canada.
Chitayat D, Wyatt PR; SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE; CANADIAN COLLEGE OF MEDICAL GENETICISTS PRENATAL DIAGNOSIS COMMITTEE. Chitayat D, et al. J Obstet Gynaecol Can. 2008 Sep;30(9):837-841. doi: 10.1016/S1701-2163(16)32949-8. J Obstet Gynaecol Can. 2008. PMID: 18845054 English, French.
Search terms included fragile X, screening, prenatal testing, pregnancy outcome, premutation, trinucleotide repeats, and ovarian failure. All study types were reviewed. Randomized controlled trial results were considered evidence of the highest quality …
Search terms included fragile X, screening, prenatal testing, pregnancy outcome, premutation, trinucleotide repeats, and ovarian f …
Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation.
van Kasteren YM, Hoek A, Schoemaker J. van Kasteren YM, et al. Fertil Steril. 1995 Aug;64(2):273-8. doi: 10.1016/s0015-0282(16)57722-x. Fertil Steril. 1995. PMID: 7615102 Free article. Clinical Trial.
OBJECTIVES: To determine the effect of pituitary suppression with a GnRH agonist (GnRH-a) on the success of ovulation induction with exogenous gonadotropins in patients with premature ovarian failure (POF). DESIGN: Placebo-controlled, randomized, doubl …
OBJECTIVES: To determine the effect of pituitary suppression with a GnRH agonist (GnRH-a) on the success of ovulation induction with exogeno …
Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization.
Schmutzler RK, Reichert C, Diedrich K, Wildt L, Diedrich C, Al-Hasani S, van der Ven H, Krebs D. Schmutzler RK, et al. Hum Reprod. 1988 Oct;3 Suppl 2:29-33. doi: 10.1093/humrep/3.suppl_2.29. Hum Reprod. 1988. PMID: 2976414 Clinical Trial.
Therefore, the gonadotrophin-releasing hormone (GnRH) agonist, D-Trp-6-LHRH, was applied to patients exhibiting premature LH surges, hyperandrogenaemia or incipient premature menopause. ...The cancellation rate of 13.4% was mainly due to insufficient follicul …
Therefore, the gonadotrophin-releasing hormone (GnRH) agonist, D-Trp-6-LHRH, was applied to patients exhibiting premature LH surges, …
The phenotypic effects of small, distal Xq deletions.
Trunca C, Therman E, Rosenwaks Z. Trunca C, et al. Hum Genet. 1984;68(1):87-9. doi: 10.1007/BF00293879. Hum Genet. 1984. PMID: 6500561
The symptoms caused by such deletions range from apparently none through irregular menstruation to secondary amenorrhea (or premature menopause) to primary amenorrhea. That the abnormal chromosome has any effects when it is inactivated may best be explained by one o …
The symptoms caused by such deletions range from apparently none through irregular menstruation to secondary amenorrhea (or premature …